The potential role of N-acetylcysteine for the treatment of Helicobacter pylori

Journal of Clinical Gastroenterology

Volumn 45, Issue 10, 2011, Pages 841-843

  Makipour, Kian ^a   Friedenberg, Frank K ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMOXICILLIN; ARGINASE; BACTERIUM LIPOPOLYSACCHARIDE; CLARITHROMYCIN; CYCLIC AMP; EXOPOLYSACCHARIDE; FLAGELLIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LANSOPRAZOLE; OMEPRAZOLE; TRYPTOPHAN; TRYPTOPHANASE; UREASE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BIOFILM; CELL DENSITY; CELL DIFFERENTIATION; CIGARETTE SMOKING; DUODENUM ULCER; ERADICATION THERAPY; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; GASTROSCOPY; GENETIC TRANSCRIPTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PERISTALSIS; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; PROTEIN PHOSPHORYLATION; PSEUDOMONAS AERUGINOSA; REVIEW; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS EPIDERMIDIS; STOMACH BIOPSY; STOMACH EPITHELIUM; STOMACH PH; TREATMENT DURATION; VIBRIO CHOLERAE;

ACETYLCYSTEINE; ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG RESISTANCE, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 80054107340     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31822be4d6     Document Type: Review

References (32)

1. Bytzer P, O'Morain C. Treatment of Helicobacter pylori. Helicobacter. 2005;10(Suppl 1):40-46.
2. Ford AC, Delaney BC, Forman D, et al. Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol. 2004;99:1833-1855.
3. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175-1186.
4. Skouloubris S, Thiberge JM, Labigne A, et al. The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo. Infect Immun. 1998;66:4517-4521.
5. Eaton KA, Krakowka S. Effect of gastric pH on ureasedependent colonization of gnotobiotic piglets by Helicobacter pylori. Infect Immun. 1994;62:3604-3607.
6. Eaton KA, Suerbaum S, Josenhans C, et al. Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect Immun. 1996;64:2445-2448.
7. Gobert AP, McGee DJ, Akhtar M, et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci U S A. 2001;98:13844-13849.
8. Gewirtz AT, Yu Y, Krishna US, et al. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis. 2004;189:1914-1920.
9. Lee SK, Stack A, Katzowitsch E, et al. Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect. 2003;5:1345-1356.
10. Yonezawa H, Osaki T, Kurata S, et al. Assessment of in vitro biofilm formation by Helicobacter pylori. J Gastroenterol Hepatol. 2010;25(suppl 1): S90-S94.
11. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318-1322.
12. Perez-Giraldo C, Rodriguez-Benito A, Moran FJ, et al. Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J Antimicrob Chemother. 1997;39:643-646.
13. Zhao T, Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 2010;10:140.
14. Karatan E, Watnick P. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Mol Biol Rev. 2009;73:310-347.
15. Del Pozo JL, Patel R. The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther. 2007;82:204-209.
16. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother. 2001;45:999-1007.
17. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358:135-138.
18. Joyce EA, Bassler BL, Wright A. Evidence for a signaling system in Helicobacter pylori: detection of a luxS-encoded autoinducer. J Bacteriol. 2000;182:3638-3643.
19. Stark RM, Gerwig GJ, Pitman RS, et al. Biofilm formation by Helicobacter pylori. Lett Appl Microbiol. 1999;28:121-126.
20. Mackay WG, Gribbon LT, Barer MR, et al. Biofilms in drinking water systems: a possible reservoir for Helicobacter pylori. J Appl Microbiol. 1998;85(suppl 1):52S-59S.
21. Carron MA, Tran VR, Sugawa C, et al. Identification of Helicobacter pylori biofilms in human gastric mucosa. J Gastrointest Surg. 2006;10:712-717.
22. Boren T, Falk P, Roth KA, et al. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science. 1993;262:1892-1895.
23. Simon PM, Goode PL, Mobasseri A, et al. Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infect Immun. 1997;65:750-757.
24. Cole SP, Harwood J, Lee R, et al. Characterization of monospecies biofilm formation by Helicobacter pylori. J Bacteriol. 2004;186:3124-3132.
25. Selbach M, Moese S, Meyer TF, et al. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun. 2002;70:665-671.
26. Millea PJ. N-acetylcysteine: multiple clinical applications. Am Fam Physician. 2009;80:265-269.
27. Olofsson AC, Hermansson M, Elwing H. N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl Environ Microbiol. 2003;69:4814-4822.
28. Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. J Clin Microbiol. 1977;5:58-61.
29. Dodd S, Dean O, Copolov DL, et al. N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther. 2008;8:1955-1962.
30. Zala G, Flury R, Wust J, et al. Omeprazole/amoxicillin: improved eradication of Helicobacter pylori in smokers because of N-acetylcysteine. Schweiz Med Wochenschr. 1994;124:1391-1397.
31. Gurbuz AK, Ozel AM, Ozturk R, et al. Effect of N-acetyl cysteine on Helicobacter pylori. South Med J. 2005;98:1095-1097.
32. Cammarota G, Branca G, Ardito F, et al. Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol. 2010;8:817-820e3.